Inventor · disambiguated record
Abhijit Dandapat
Also filed as: DANDAPAT ABHIJIT
10 granted patents·6 pending applications·33 citations·filing 2007–2024
86Inventor score
Top patents by PatentIndex Score
16 records- 0196US11077143B2Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cellsNANTKWEST INC·Filed 2019·Granted Aug 3, 2021·16 cites·9 claims
- 0294US11643452B2Fc-epsilon carIMMUNITYBIO INC·Filed 2021·Granted May 9, 2023·6 cites·8 claims
- 0393US12403178B2Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)IMMUNITYBIO INC·Filed 2023·Granted Sep 2, 2025·2 cites·22 claims
- 0489US12473348B2Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cellsIMMUNITYBIO INC·Filed 2021·Granted Nov 18, 2025·1 cites·18 claims
- 0589US12473347B2Elimination of PD-L1-positive malignancies by PD-L1 chimeric antigen receptor-expressing NK cellsIMMUNITYBIO INC·Filed 2021·Granted Nov 18, 2025·1 cites·18 claims
- 0687US12435122B2Fc-epsilon CARIMMUNITYBIO INC·Filed 2019·Granted Oct 7, 2025·3 cites·8 claims
- 0787US11813292B2Use of CD33CAR modified high affinity NK cells (t-haNK) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on NK cell activity)IMMUNITYBIO INC·Filed 2019·Granted Nov 14, 2023·2 cites·3 claims
- 0881US11591573B2Methods of preparing a primary cell sampleCELCUITY INC·Filed 2018·Granted Feb 28, 2023·2 cites·10 claims
- 0980US2025073305A1Use of cd33car modified high affinity nk cells (t-hank) to reduce myeloid-derived suppressor cells suppressor activity (or reduce negative impact on nk cell activity)IMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 1074US12215356B2Methods of preparing a primary cell sampleCELCUITY INC·Filed 2023·Granted Feb 4, 2025·0 cites·10 claims
- 1174US2023272042A1Fc-epsilon carIMMUNITYBIO INC·Filed 2023·Application pending·0 cites
- 1252US2022017594A1Il-2 dependent nk-92 cells with stable fc receptor expressionNANTKWEST INC·Filed 2019·Application pending·0 cites
- 1352US2021040175A1Artificial Target Cells for in-vitro CAR Cytotoxicity and ADCC validationNANTKWEST INC·Filed 2020·Application pending·0 cites
- 1451US2023172982A1Elimination of BCMA-positive malignancies by CAR expressing NK cellsIMMUNITYBIO INC·Filed 2020·Application pending·0 cites
- 1550US12221629B2Methods for producing fibroadipogenic progenitor cellsUNIV MINNESOTA·Filed 2021·Granted Feb 11, 2025·0 cites·15 claims
- 1644US2008199434A1Compositions and methods for the treatment of cardiovascular conditionsUNIV ARKANSAS·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Abhijit Dandapat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →